Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Study Objective. To describe the pharmacokinetics of fluconazole in immune‐compromised children with leukemia or other hematologic disease. Design. Prospective. Setting. Children's Health Care‐Minneapolis hematology/oncology inpatient ward and outpatient clinic. Patients. Ten immune‐compromised children (mean ± SD age 7.4 ± 4.0 yrs, weight 31.6 ± 25.9 kg) with leukemia or other hematologic disease. Interventions. Serum was sampled before and after a single 6‐mg/kg intravenous dose and after seven oral 3‐mg/kg doses of fluconazole. Measurements and Main Results. Mean (SD) pharmacokinetics were distribution half‐life 1.67 (1.25) hours, elimination half‐life 15.62 (3.21) hours, total body clearance 0.63 (0.19) ml/min/kg, volume of distribution for the central compartment 0.56 (0.10) L/kg, volume of distribution at steady state 0.77 (0.12) L/kg, absorption half‐life 0.41 (0.26) hour, and oral bioavailability 0.92 (0.09). Volume of distribution for the central compartment was highly correlated with body surface area (r 2=0.891) and weight (r 2=0.949). Volume of distribution at steady state correlated with body surface area (r 2=0.986), and total body clearance correlated with body surface area (r 2=0.867). Conclusions. Fluconazole elimination was well described using a two‐compartment model. Oral absorption was rapid and nearly complete. Children have a larger volume of distribution for the central compartment and faster elimination rate than adults. Body surface area and weight are important factors in determining pharmacokinetics in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238
Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life
Saxén, H., Hoppu, K., & Pohjavuori, M. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.147 · Cited by 127
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81975-4 · Cited by 120
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
“of distribution and longer half-life [63, 64]; it has been recently”
BackgroundPerfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
“The pharmacokinetics of fluconazole vary with age [89–92].”
BackgroundPractice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Metadata
- Authors
- Seay, R. E., Larson, T. A., Toscano, J. P., Bostrom, B. C., O'Leary, M. C., & Uden, D. L.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 1995-01-02
- Volume
- 15
- Issue
- 1
- Pages
- 52-58
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W4388202839
- Cited by
- 43
- References
- 3
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease. https://app.cochat.ai/papers/10.1002/j.1875-9114.1995.tb04331.x
- The paper
- Seay, R. E., Larson, T. A., Toscano, J. P., Bostrom, B. C., O'Leary, M. C., & Uden, D. L. (1995). Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/j.1875-9114.1995.tb04331.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.